Clinical trial
Continuous Glucose Monitoring (CGM) in Type 2 Diabetes (T2D) Basal Insulin Users: The Mobile Study (MOBILE)
NCT03566693 is registered in ClinicalTrials.gov with DexCom, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Continuous Glucose Monitoring (CGM) in Type 2 Diabetes (T2D) Basal Insulin Users: The Mobile Study (MOBILE)
- Lead sponsor
- DexCom, Inc.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- July 30, 2018
- Completion date
- January 4, 2021
- Enrollment
- 176 (actual)
- Sites
- 15
Conditions
As the registry lists them; a condition with its own page is linked.